Marien Rouchon currently serves as a Medical Advisor for France and Belgium at Merus N.V. since July 2024. Prior to this role, Marien Rouchon worked as a Field-Based Medical Advisor at Morphosys from January 2021 to September 2024, where key responsibilities included the setup of three clinical studies in hemato-oncology, notably the MANIFEST-2 phase 3 study focused on myelofibrosis and the FrontMIND phase 3 study targeting diffuse large B-cell lymphoma. Marien Rouchon holds a Master’s degree in Intelligence Marketing from HEC Paris and a Doctorat in Pharmacie from Université d'Auvergne.
This person is not in any teams
This person is not in any offices